The Short-term Efficacy of Gastrodia and Uncaria Drink in Treating Hypertension
- Registration Number
- NCT02156024
- Lead Sponsor
- Shanghai Institute of Hypertension
- Brief Summary
The purpose of this study is
1. To determine whether the Gastrodia and Uncaria Drink is effective in the treatment of masked hypertensive patients below 70 years.
2. To find out the suitable groups for the Gastrodia and Uncaria Drink treatment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
- age between 18 to 70 years
- didn't use any anti-hypertension drugs within 2 weeks
- stage 1 masked hypertensive patients, which means clinic blood pressure<140/90 mmHg,however the daytime(8:00-18:00) 24h ambulatory blood pressure between 135/85 and 150/95mmHg
- be willing to participate in the trials and able to finish clinic visit
Exclusion Criteria
- secondary hypertension
- be allergic to the clinical trial medicine
- occurrence of stroke, CKD, myocardial infarction within 2 years
- dysfunction of liver or kidney and fundus hemorrhage
- arrhythmia
- ALT, AST, TBL upper the twice of normal range, Scr≥2.0mg/dl, K+≥5.5mmol/L, Urine protein≥2+
- psychiatric disorders
- pregnant, breastfeeding
- other serious conditions in which is not fit for the study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Gastrodia and Uncaria Drink Gastrodia and Uncaria Drink Gastrodia and Uncaria Drink, 1 dose at a time, twice a day, duration: 4 weeks
- Primary Outcome Measures
Name Time Method blood pressure March 1,2015
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Ruijin Hospital
🇨🇳Shanghai, Shanghai, China